Ralf Janknecht to Protein Kinase Inhibitors
This is a "connection" page, showing publications Ralf Janknecht has written about Protein Kinase Inhibitors.
Connection Strength
0.138
-
Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Mol Cancer. 2014 May 06; 13:103.
Score: 0.106
-
Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase. J Biol Chem. 1997 Feb 14; 272(7):4219-24.
Score: 0.032